# Serum Maresin-1 Predicts the Severity of Severe Acute Pancreatitis

> **NCT03364920** · — · UNKNOWN · sponsor: **Weiqin Li** · enrollment: 200 (estimated)

## Conditions studied

- Pancreatitis, Acute

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03364920
- **Lead sponsor:** Weiqin Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2019-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03364920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03364920, "Serum Maresin-1 Predicts the Severity of Severe Acute Pancreatitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03364920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*